IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Lonza Adds High-Potency Capacity

10:06 AM MDT | June 28, 2007 | Chemical Week Editorial Staff

Lonza says it will build a plant at Visp, Switzerland to produce high-potency active pharmaceutical ingredients at large scale. The facility, which is due to cost SF80 million ($64 million), is scheduled to open in mid-2008. “The project provides Lonza with a unique competitive advantage by being the sole custom manufacturer capable of handling large-scale manufacturing in this arena,” Lonza...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa